RBC and WBC fatty acid composition following consumption of an omega 3 supplement: Lessons for future clinical trials

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Witte, Theodore R ^a   Salazar, Alexander J ^a   Ballester, Oscar F ^a   Hardman, W Elaine ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID;

ARTICLE; CELL TYPE; CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DRUG DOSE INCREASE; ERYTHROCYTE; FATTY ACID ANALYSIS; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOCYTE; LIPID COMPOSITION; LYMPHATIC LEUKEMIA; BIOSYNTHESIS; CHEMISTRY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL (TOPIC); CYTOLOGY; DISEASE COURSE; METABOLISM; PILOT STUDY;

ANIMALIA;

CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; ERYTHROCYTES; FATTY ACIDS; FATTY ACIDS, OMEGA-3; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES; LIPIDS; NF-KAPPA B; PILOT PROJECTS;

EID: 77950415883     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-31     Document Type: Article

References (23)

1. Human requirement for N-3 polyunsaturated fatty acids. AP Simopoulos, Poult Sci 2000 79 961 970 10901194
2. (n-3) fatty acids and cancer therapy. WE Hardman, J Nutr 2004 134 3427S 3430S 15570049 (Pubitemid 39587585)
3. Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial. SD Poppitt P Kilmartin P Butler GF Keogh, Lipids Health Dis 2005 4 30 30 10.1186/1476-511X-4-30 16329761 (Pubitemid 43136443)
4. The effects of fish oil and high or low linoleic acid intake on fatty acid composition of human peripheral blood mononuclear cells. CT Damsgaard H Frokiaer L Lauritzen, Br J Nutr 2008 99 147 154 10.1017/S0007114507791900 17663804 (Pubitemid 350286148)
5. Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice. WE Hardman MP Moyer IL Cameron, Br J Cancer 2002 86 983 988 10.1038/sj.bjc.6600175 11953833
6. Dietary canola oil suppressed growth of implanted MDA-MB 231 human breast tumors in nude mice. WE Hardman, Nutr Cancer 2007 57 177 183 17571951
7. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 human breast cancer xenografts. WE Hardman CPR Avula G Fernandes IL Cameron, Clin Cancer Res 2001 7 2041 2049 11448922 (Pubitemid 32994843)
8. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. WS Harris JV Pottala SA Sands PG Jones, Am J Clin Nutr 2007 86 1621 1625 18065578
9. Effects of dietary n-3 polyunsaturated fatty acids on T-cell membrane composition and function. KC Switzer DN McMurray RS Chapkin, Lipids 2004 39 1163 1170 10.1007/s11745-004-1343-y 15736911
10. The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in patients with postoperative trauma. BJ Morlion E Torwesten H Lessire G Sturm BM Peskar P Furst, et al. Metabolism 1996 45 1208 1213 10.1016/S0026-0495(96)90237-1 8843174 (Pubitemid 26337665)
11. Biological variability of blood omega-3 biomarkers. WS Harris RM Thomas, Clin Biochem 2010 43 338 340 10.1016/j.clinbiochem.2009.08.016 19733159
12. Omega-3 polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. G ais-Pont YM Dupertuis MP Kossovsky P Nouet AS Allal F Buchegger, et al. Nutrition 2006 22 931 939 10.1016/j.nut.2006.05.012 16814518 (Pubitemid 44234013)
13. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. PD Biondo DN Brindley MB Sawyer CJ Field, J Nutr Biochem 2008 19 787 796 10.1016/j.jnutbio.2008.02.003 18602809
14. Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid. S Colas L Paon F Denis M Prat P Louisot C Hoinard, et al. Int J Cancer 2004 109 449 454 10.1002/ijc.11725 14961586 (Pubitemid 38252776)
15. Dietary omega-3 fatty acids and ionizing irradiation on human breast cancer xenograft growth and angiogenesis. WE Hardman L Sun N Short IL Cameron, Cancer Cell Int 2005 5 12 10.1186/1475-2867-5-12 15860128 (Pubitemid 41460754)
16. 3on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet. WE Hardman CJ Barnes CW Knight IL Cameron, Br J Cancer 1997 76 347 354 9252202
17. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. IA Shaikh I Brown AC Schofield KW Wahle SD Heys, Prostate 2008 68 1635 1646 10.1002/pros.20830 18668525
18. Effects of polyunsaturated fatty acids on vincristine-resistance in human neuroblastoma cells. S Ikushima F Fujiwara S Todo S Imashuku, Anticancer Res 1991 11 1215 1220 1888152
19. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines. QY Liu BK Tan, Life Sci 2000 67 1207 1218 10.1016/S0024-3205(00)00714-1 10954054
20. Cell-specific enhancement of doxorubicin toxicity in human tumour cells by docosahexaenoic acid. PK Rudra HE Krokan, Anticancer Res 2001 21 29 38 11299749
21. Nutritional modulation of antitumor efficacy and diarrhea toxicity related to irinotecan chemotherapy in rats bearing the ward colon tumor. H Xue MB Sawyer CJ Field LA Dieleman VE Baracos, Clin Cancer Res 2007 13 7146 7154 10.1158/1078-0432.CCR-07-0823 18056195 (Pubitemid 350276901)
22. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B Study 9473. CP Burns S Halabi GH Clamon V Hars BA Wagner RJ Hohl, et al. Clin Cancer Res 1999 5 3842 3947 (Pubitemid 30013768)
23. Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. WE Hardman G Ion, Nutr Cancer 2008 60 666 674 10.1080/01635580802065302 18791931